SRRM2 — Serine/Arginine Repetitive Matrix 2
Overview
SRRM2 (Serine/Arginine Repetitive Matrix 2) is a nuclear protein belonging to the SR (serine/arginine-rich) family of splicing regulators. The gene is located on chromosome 19q13.2 and encodes a 300-kDa protein characterized by multiple serine/arginine-rich domains interspersed throughout its structure. SRRM2 functions as a non-snRNP splicing factor that plays a critical role in constitutive and alternative pre-mRNA splicing. The protein is predominantly localized to nuclear speckles, subnuclear domains enriched in splicing factors and nascent pre-mRNA transcripts. SRRM2 has emerged as a significant player in neurodegenerative diseases, particularly in the context of motor neuron degeneration and neuromuscular dysfunction.
Function/Biology
SRRM2 operates as a splicing coactivator that promotes spliceosome assembly and pre-mRNA processing. The protein contains three characteristic domains: an N-terminal RNA recognition motif (RRM), a central region rich in serine and arginine residues (RS domain), and a C-terminal region essential for protein-protein interactions. These structural features enable SRRM2 to bind both RNA substrates and other splicing components, facilitating their coordinated assembly on pre-mRNA targets.
...SRRM2 — Serine/Arginine Repetitive Matrix 2
Overview
SRRM2 (Serine/Arginine Repetitive Matrix 2) is a nuclear protein belonging to the SR (serine/arginine-rich) family of splicing regulators. The gene is located on chromosome 19q13.2 and encodes a 300-kDa protein characterized by multiple serine/arginine-rich domains interspersed throughout its structure. SRRM2 functions as a non-snRNP splicing factor that plays a critical role in constitutive and alternative pre-mRNA splicing. The protein is predominantly localized to nuclear speckles, subnuclear domains enriched in splicing factors and nascent pre-mRNA transcripts. SRRM2 has emerged as a significant player in neurodegenerative diseases, particularly in the context of motor neuron degeneration and neuromuscular dysfunction.
Function/Biology
SRRM2 operates as a splicing coactivator that promotes spliceosome assembly and pre-mRNA processing. The protein contains three characteristic domains: an N-terminal RNA recognition motif (RRM), a central region rich in serine and arginine residues (RS domain), and a C-terminal region essential for protein-protein interactions. These structural features enable SRRM2 to bind both RNA substrates and other splicing components, facilitating their coordinated assembly on pre-mRNA targets.
The RS domains function as protein interaction modules, mediating recruitment of other SR proteins and core spliceosomal components to nascent transcripts. SRRM2 specifically enhances splicing of exons with weak splice sites by recruiting additional splicing machinery components. The protein interacts extensively with other SR proteins, including SRSF1 (serine/arginine-rich splicing factor 1) and SRSF2, as well as with core snRNPs (small nuclear ribonucleoproteins) of the spliceosome.
SRRM2 also participates in transcriptional regulation beyond its splicing functions. The protein can influence histone modifications and chromatin structure at actively transcribed loci, suggesting roles in coordinating transcription and RNA processing. Additionally, SRRM2 shuttles between the nucleus and cytoplasm, though its primary function resides in the nuclear compartment.
Role in Neurodegeneration
SRRM2 gained prominence in neurodegeneration research through genetic studies identifying mutations in ALS (amyotrophic lateral sclerosis) and related motor neuron diseases. Specifically, SRRM2 mutations have been identified in patients with ALS and atypical parkinsonism, highlighting the critical importance of proper splicing regulation in motor neuron survival and function.
The neurodegenerative phenotype associated with SRRM2 dysfunction likely stems from disrupted splicing of critical neuronal transcripts. Loss of SRRM2 function impairs the proper processing of genes essential for neuronal function, particularly those involved in cytoskeletal dynamics, RNA metabolism, and protein homeostasis. The motor neuron vulnerability may reflect particular dependence on accurate splicing of motor neuron-specific transcripts and heightened sensitivity to splicing dysregulation.
Dysfunction of SRRM2 can lead to accumulation of improperly spliced transcripts, potentially generating toxic proteins or truncated versions lacking essential functional domains. This splicing dysregulation cascades through networks of genes controlling neuronal integrity, contributing to progressive motor neuron degeneration.
Molecular Mechanisms
ALS-associated SRRM2 mutations typically involve truncations or deletions that disrupt the C-terminal regions critical for protein-protein interactions. These mutations impair SRRM2's ability to form functional complexes with other splicing factors and spliceosomal components. The consequence is widespread splicing dysregulation affecting hundreds of neuronal transcripts.
Loss of SRRM2 function specifically compromises splicing of genes encoding RNA-binding proteins, cytoskeletal regulators, and proteins involved in axonal transport. This creates a secondary cascade of splicing errors, amplifying the initial defect. Additionally, SRRM2 dysfunction appears to specifically impair neuron-specific alternative splicing events, explaining the selective vulnerability of motor neurons.
Clinical/Research Significance
SRRM2 mutations represent a rare but significant genetic cause of ALS, accounting for approximately 0.1-0.5% of familial ALS cases. The discovery of SRRM2 in motor neuron disease expanded understanding of splicing dysregulation as a fundamental mechanism in neurodegeneration, complementing findings in other splicing-associated genes like FUS and TARDBP.
Current research explores SRRM2-mediated splicing signatures as potential biomarkers for ALS and related disorders. Additionally, therapeutic strategies targeting splicing modulation through antisense oligonucleotides or small molecules represent promising avenues for SRRM2-associated disease.
- SRSF1, SRSF2 – other SR splicing factors interacting with SRRM2
- Spliceosome – molecular machine SRRM2 regulates
- FUS, TARDBP – alternative
Pathway Diagram
The following diagram shows the key molecular relationships involving SRRM2 — Serine/Arginine Repetitive Matrix 2 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)